nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2005-9-4-104-107nefr-731Research ArticleПРОГРАММА НЕПРЕРЫВНОГО ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ПО НЕФРОЛОГИИPROGRAM ON CONTINUOUS POSTGRADUATE EDUCATION ON NEPHROLOGYФАКТОРЫ РОСТА И ГЛОМЕРУЛОСКЛЕРОЗ ПРИ ДИАБЕТИЧЕСКОЙ НЕФРОПАТИИGROWTH FACTORS OF GLOMERULOSCLEROSIS IN DIABETIC NEPHROPATHYШишкинА. Н.ShishkinA. N.
Кафедра терапии, медицинский факультет
Санкт-Петербургский государственный университетRussian Federation20051004200594104107Copyright © Шишкин А.Н., 20052005Шишкин А.Н.Shishkin A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/731
Факторы роста и гломерулосклероз при диабетической нефропатии.
Growth factors of glomerulosclerosis in diabetic nephropathy.
диабетическая нефропатияфакторы ростагломерулосклерозренинангиотензиновая системаdiabetic nephropathygrowth factorsglomerulosclerosisreninangiotensin systemReferencesZiyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993; 22:736744Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993; 22:736744Sharma K, Guo I, Jin Y, Ericksen M. AntiTGFβ antibody attenuates renal hypertrophy and matrix expansion in diabetic mice. J Am Soc Nephrol 1994; 5: 972978Sharma K, Guo I, Jin Y, Ericksen M. AntiTGFβ antibody attenuates renal hypertrophy and matrix expansion in diabetic mice. J Am Soc Nephrol 1994; 5: 972978Ceol M, Nerlich A, Baggio B. Increased glomerular α1 (IY) collagen expression and deposition in long–term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab Invest 1996; 74: 484495Ceol M, Nerlich A, Baggio B. Increased glomerular α1 (IY) collagen expression and deposition in long–term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab Invest 1996; 74: 484495Leehey DJ, Song RN, Alavi N, Singh AK. Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 1995; 44: 929935Leehey DJ, Song RN, Alavi N, Singh AK. Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 1995; 44: 929935Gambaro G, Baggio B. Growth factors and the kidney in diabetes. Crit Rev Lab Clin Med 1998; 35: 117151Gambaro G, Baggio B. Growth factors and the kidney in diabetes. Crit Rev Lab Clin Med 1998; 35: 117151Vriese AS, Tilton RG, Elger M et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12: 9931000Vriese AS, Tilton RG, Elger M et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001; 12: 9931000Young ВA, Johnson RJ, Alpers CE et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995; 47: 935944Young ВA, Johnson RJ, Alpers CE et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995; 47: 935944Петрищев НН, Власов ТД. Физиология и патофизиология эндотелия. В: Петрищев НН, ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. Издво СПбГМУ, 2003; 4372Петрищев НН, Власов ТД. Физиология и патофизиология эндотелия. В: Петрищев НН, ред. Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. Издво СПбГМУ, 2003; 4372Yevdokimova N, Wahab NA, Mason R. Thrombospondin 1 is the key activator of TGFβ 31 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 2001;12: 703712Yevdokimova N, Wahab NA, Mason R. Thrombospondin 1 is the key activator of TGFβ 31 in human mesangial cells exposed to high glucose. J Am Soc Nephrol 2001;12: 703712Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794814Ferrara N. Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999; 56: 794814Kang DH, Anderson S, Kim YG et al. Role of the microvascular endotelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806812Kang DH, Anderson S, Kim YG et al. Role of the microvascular endotelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806812Masuda Y, Shimizu A, Mori T et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001;159: 599608Masuda Y, Shimizu A, Mori T et al. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol 2001;159: 599608Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes 1991; 40: 653659Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes 1991; 40: 653659Saito Y, Kida H, Takeda SI et al. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions. Kidney Int 1988; 34: 389396Saito Y, Kida H, Takeda SI et al. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions. Kidney Int 1988; 34: 389396Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 1993; 36: 189194Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia 1993; 36: 189194Min W, Yamanaka N. Threedimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virch Arch A Pathol Anat 1993; 423: 201207Min W, Yamanaka N. Threedimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virch Arch A Pathol Anat 1993; 423: 201207Hovind P, Rossing P, Tarnow L. Progression of diabetic nephropathy. Kidney Int 2001; 59: 702709Hovind P, Rossing P, Tarnow L. Progression of diabetic nephropathy. Kidney Int 2001; 59: 702709Grone HJ. Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients? Nephrol Dial Transplant 1995; 10: 761763Grone HJ. Angiogenesis and vascular endothelial growth factor (VEGF): is it relevant in renal patients? Nephrol Dial Transplant 1995; 10: 761763Kang DH, Anderson S, Kim YG et al. Impaired angiogenesis in the aging kidney: Potential role of VEGF and TSP1 in renal disease. Am J Kid Disll 2001; 37: 601611Kang DH, Anderson S, Kim YG et al. Impaired angiogenesis in the aging kidney: Potential role of VEGF and TSP1 in renal disease. Am J Kid Disll 2001; 37: 601611Shulman K, Rosen S, Tognazzi K et al. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 1996; 7: 661666Shulman K, Rosen S, Tognazzi K et al. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 1996; 7: 661666Kanellis J, Fraser S, Katerelos M, Power DA. Vascular endothe-lial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 2000; 278: F905 F915Kanellis J, Fraser S, Katerelos M, Power DA. Vascular endothe-lial growth factor is a survival factor for renal tubular epithelial cells. Am J Physiol Renal Physiol 2000; 278: F905 F915Yamamoto T, Nakamura T, Noble NA et al. Expression of transforming growth factor p is elevated in human and experimental diabetic nephropathy. Proc Nad Acad Sci USA 1993; 90: 18141818Yamamoto T, Nakamura T, Noble NA et al. Expression of transforming growth factor p is elevated in human and experimental diabetic nephropathy. Proc Nad Acad Sci USA 1993; 90: 18141818Аugust Ph. Overview: mechanisms of hypertension: cells, hormones, and the kidney. J Am Soc Nephrol 2004; 15: 1971 1973Аugust Ph. Overview: mechanisms of hypertension: cells, hormones, and the kidney. J Am Soc Nephrol 2004; 15: 1971 1973Tarnow L. Diabetic nephropathy. Pathogenetic aspects and car-diovascular risk factors. Dan Med Bull 2002; 49: 1942Tarnow L. Diabetic nephropathy. Pathogenetic aspects and car-diovascular risk factors. Dan Med Bull 2002; 49: 1942Cheng HF, Burns KD, Harris RC. Reduced proximal tubule angiotensin II receptor expression in streptozotocin induced diabetes mellitus. Kidney Int 1994; 46: 16031610Cheng HF, Burns KD, Harris RC. Reduced proximal tubule angiotensin II receptor expression in streptozotocin induced diabetes mellitus. Kidney Int 1994; 46: 16031610Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin IIinduced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor. J Clin Invest 1993; 92: 13661372Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin IIinduced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor. J Clin Invest 1993; 92: 13661372Border WA, Okuda S, Languino LR et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor. Nature 1990; 346: 371374Border WA, Okuda S, Languino LR et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor. Nature 1990; 346: 371374Jacobsen P, Tarnow L, Cartensen B, Hovind P. Genetic variation in the reninangiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 28432850Jacobsen P, Tarnow L, Cartensen B, Hovind P. Genetic variation in the reninangiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 28432850
The authors declare that there are no conflicts of interest present.